Trinity Biotech
TRIB
HK$5.89
Share price
10.12%
Change (1 day)
-64.78%
Change (1 year)
Categories
Trinity Biotech (TRIB) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : HK$1.08 Billion
According to Trinity Biotech 's latest financial reports the company's total liabilities are HK$1.08 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Trinity Biotech - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | HK$0.65 B | -11.59% |
| 2022-12-31 | HK$0.73 B | -20.76% |
| 2021-12-31 | HK$0.92 B | -9.58% |
| 2020-12-31 | HK$1.02 B | 4.47% |
| 2019-12-31 | HK$0.98 B | 16.79% |
| 2018-12-31 | HK$0.84 B | -15.59% |
| 2017-12-31 | HK$0.99 B | -8.61% |
| 2016-12-31 | HK$1.09 B | -5.91% |
| 2015-12-31 | HK$1.16 B | 226.34% |
| 2014-12-31 | HK$0.35 B | 5.53% |
| 2013-12-31 | HK$0.33 B | 55.18% |
| 2012-12-31 | HK$0.21 B | 38.69% |
| 2011-12-31 | HK$0.15 B | 2.76% |
| 2010-12-31 | HK$0.15 B | -62.98% |
| 2009-12-31 | HK$0.41 B | -16.23% |
| 2008-12-31 | HK$0.49 B | -20.34% |
| 2007-12-31 | HK$0.61 B | -3.1% |
| 2006-12-31 | HK$0.63 B | 61.08% |
| 2005-12-31 | HK$0.39 B | 46.63% |
| 2004-12-31 | HK$0.26 B | -8.06% |
| 2003-12-31 | HK$0.29 B | 39.51% |
| 2002-12-31 | HK$0.21 B | 31.5% |
| 2001-12-31 | HK$0.15 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 OraSure Technologies OSUR | HK$0.48 B | -55.71% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | HK$22.34 B | 1,956.39% | 🇺🇸 USA |
 Abbott Laboratories ABT | HK$254.11 B | 23,286.85% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | HK$0.35 B | -67.64% | 🇺🇸 USA |
 QuidelOrtho QDEL | HK$27.18 B | 2,401.90% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$388.85 B | 35,688.00% | 🇺🇸 USA |
 Danaher DHR | HK$221.74 B | 20,307.88% | 🇺🇸 USA |